The aim of the present study is to test a hypothesis that 5-HT 1A and 5-HT 2C receptors in the amygdala play an important role in the regulation of anxiety behaviors. We examined alterations in anxiety-like behaviors after manipulation of the expression of 5-HT 1A and 5-HT 2C receptors in the amygdala using recombinant adenovirus approaches. Recombinant adenoviruses containing a 5-HT 1A promoter-controlled 5-HT 1A antisense sequence or a 5-HT 2C promoter-controlled 5-HT 2C sense sequence were injected into the amygdala. 
Introduction
Serotonin (5-HT) is known to regulate anxiety behaviors. Among the fifteen 5-HT receptors, 5-HT 1A and 5-HT 2C receptors have gained particular attention. 5-HT 1A receptor agonists produce anxiolytic effects (De Vry, 1995; Lacivita et al., 2008) . Mice with a genetic deficit in 5-HT 1A receptors showed an increase in anxiety-like behaviors (Gross et al., 2000; Heisler et al., 1998; Olivier et al., 2001; Ramboz et al., 1998) . On the other hand, a 5-HT agonist with a relatively high affinity for 5-HT 2C receptors, m-chlorophenylpiperazine (mCPP), induces anxiogenic effects (Gibson et al., 1994) , which can be blocked by 5-HT 2C receptor antagonists (Bagdy et al., 2001; Hackler et al., 2007) . 5-HT 2C receptor knockout mice displayed decreases in anxiety-like behavior (Heisler et al., 2007) . These data suggest that activation of 5-HT 1A receptors may play anxiolytic effects, whereas stimulation of 5-HT 2C receptors produces an anxiogenic effect. However, the mechanisms and neurocircuitries mediating these effects of 5-HT 1A and 5-HT 2C receptors are still unclear.
The amygdala is known as a fear center. It is involved in the regulation of emotions and fear learning and memory (LeDoux, 2000) . The amygdala can be divided into two subregions, the basolateral complex (including the lateral, basolateral and basomedial nuclei) and the centromedial subdivision (containing the central nucleus, medial nucleus and part of the bed nucleus of stria terminalis) (LeDoux, 2000; Sah et al., 2003) . Evidence suggests that the basolateral complex receives sensory inputs of fear stimuli and conveys the information to the central nucleus, which further sends signals to other brain regions to express fear behaviors (LeDoux, 2000) . The basolateral complex is vital for the acquisition of fear memory, whereas the central nucleus may be related to the expression of the fear memory. 5-HT 1A and 5-HT 2C receptors are relatively abundant in the amygdala.. The 5-HT 1A receptors are mainly located in the central nucleus, whereas 5-HT 2C receptors are rich in the basolateral nucleus (Li et al., 1997; Li et al., 2000; Li et al., 2003) . Our previous study demonstrated that 5-HT 1A receptors are decreased and 5-HT 2C receptors are increased in the amygdala of mice lacking 5-HT transporters (Li et al., 2000; Li et al., 2003) . Consistent with the results, the 5-HT transporter knockout mice showed an increase in anxiety-like behaviors (Holmes et al., 2003b) . Furthermore, stress-induced increases in c-fos expression in the amygdala are blunted in 5-HT 2C receptor knockout mice (Heisler et al., 2007) . These data suggest that the amygdaloid 5-HT 1A and 5-HT 2C receptors may be involved in the regulation of anxiety-like behaviors.
Several studies have been reported on the role of amygdaloid 5-HT 1A (Gonzalez et al., 1996; Graeff et al., 1993; Zangrossi and Graeff, 1994) and 5-HT 2C receptors (Campbell and Merchant, 2003; Christianson et al., 2010; de Mello Cruz et al., 2005) in the regulation of anxiety-like behaviors in rats using pharmacological approaches. The results from these studies were not consistent, especially those concerning the effects of amygdaloid 5-HT 1A receptors on anxiety-like behaviors. For example, Graeff et al reported an anxiogenic effect of activation of 5-HT 1A receptor in the amygdala (Graeff et al., 1993) . On the other hand, Gonzalez et al. and Zangrossi and Gaeff showed that activation of 5-HT 1A receptors in the amygdala did not alter anxiety-like behaviors tested by the EPM (Gonzalez et al., 1996; Graeff et al., 1993; Zangrossi and Graeff, 1994) . Furthermore, these data were contradictory with the data observed in 5-HT 1A knockout mice and serotonin transporter knockout mice. In these mice, a lack or reduction of 5-HT 1A receptors in the amygdala increased anxietylike behaviors (Gross et al., 2000; Heisler et al., 1998; Holmes et al., 2003a; Li et al., 2000; Olivier et al., 2001; Ramboz et al., 1998) . In contrast, the effects of 5-HT 2C receptors in the amygdala were more consistent. Two studies reported that activation of 5-HT 2C receptors in the basolateral amygdala produced an anxiogenic effects in EPM test (Campbell and Merchant, 2003; de Mello Cruz et al., 2005) , although locomotor activity was also reduced by the 5-HT 2C receptor agonists. Furthermore, Christianson et al reported recently that 5-HT 2C receptors in the BLA are related to uncontrollable traumatic stress-induced anxietylike behavior in rats (Christianson et al., 2010) . To date, no study has reported using molecular approaches to investigate the effects of 5-HT 1A and 5-HT 2C receptors in the amygdala on the anxiety-like behaviors.
The aim of the present studies was to test the hypothesis that amygdaloid 5-HT 1A and 5-HT 2C receptors are related to anxiolytic and anxiogenic effects, respectively. Recombinant adenoviruses containing a 5-HT 1A promoter-controlled 5-HT 1A antisense sequence (P 1A -5HT 1A -AS-Ad) or a 5-HT 2C promoter-controlled 5-HT 2C sense sequence (P 2C -5-HT 2C -S-Ad) was used to manipulate the expression of 5-HT 1A receptors and 5-HT 2C receptors in the amygdala. Since expression of 5-HT 1A antisense and 5-HT 2C sense sequences was controlled by 5-HT 1A and 5-HT 2C promoter, respectively, the alterations in the expression of 5-HT 1A and 5-HT 2C receptors selectively occurred in the 5-HT 1A and 5-HT 2C receptor-positive cells, respectively. The EPM, a typical test for anxiety-like behavior, was used to examine the impact of amygdaloid 5-HT 1A and 5-HT 2C receptor expression. Another behavioral test, the open field test, was used to exclude possible changes in the locomotor activity and was also used as an indicator for anxiety-like behavior in mice by measuring time spent in the center of the open field. These studies provided direct evidence concerning the involvement of amygdaloid 5-HT 1A and 5-HT 2C receptors in the regulation of anxiety behaviors.
Material and methods
2.1. Generation of recombinant adenovirus containing 5-HT 2C promoter-controlled 5-HT 2C sense sequence (P 2C -5-HT 2C -S-Ad)
Recombinant adenovirus containing 5-HT 1A promoter-controlled 5-HT 1A antisense sequence (P 1A -5-HT 1A -AS-Ad) was generated and evaluated, as described previously (Li et al., 2004) . To generate P 2C -5-HT 2C -S-Ad, a fragment of 5-HT 2C promoter sequence (Forward primer: 5′-AGTTGCAGCCATCCTTTCTG-3′ and reverse primer: 5′-GCAAGTCGACCTCCTGTGG-3′ encoding 28-1822 bp, Access No. S62283) and the 5-HT 2C sense sequence (Forward primer: 5′-GGAGGTCGACTTGCCGGC-3′ and reverse primer: 5′-CTTTTGTCACACAGCAGTATTTAC-3′, encoding 364-2200 bp, Access No. NM_008312) was amplified by PCR. The promoter fragment contains a proximal promoter (28-1275bp, Access No. S62283) and part of the 5′-untranslated mRNA region (5′UTR) (1276-1822 bp, Access No. S62283). The 5′UTR overlaps with the PCR product of 5-HT 2C sense sequence, which allowed the promoter and 5-HT 2C sense fragments to be ligated using a Sal I site. The PCR products were inserted into a TOPO pCRII vector (Invitrogen Co, Carlsbad, CA). After verification of the constructs by restriction enzyme digestion followed by sequencing, the 5-HT 2C promoter was inserted into Kpn I and Sal I sites of an Ad-track shuttle vector (He et al., 1998) . Then the 5-HT 2C sense sequence was inserted into Sal I and Xho I sites of the 5-HT 2C promoter-containing Ad-track. Thus, the construct contains 1247 base pairs upstream of the 5-HT 2C promoter region and 5-HT 2C mRNA sequence (Ad-track-P 2C -5-HT 2C -S) (Fig. 1A) . We included 5′-untranslated coding region of 5-HT 2C mRNA in the construct because we found that this region is necessary for in vivo expression of 5-HT 2C receptors. The Ad-track-P 2C -5-HT 2C -S was then recombined with an adenoviral vector (Ad-Easy-1) and high titer virus (10 10-12 active viral particle/ml) was prepared as previously described (He et al., 1998; Li et al., 2004) .
Animal studies
2.2.1. Animals-Female C57BL/6 mice were purchased from Taconic Farm Inc. (Hudson, NY). Use of female mice was to be comparable to serotonin transporter knockout mice that showed more anxiety in female than male mice. The animals were 8 weeks old with body weights of 20-25g. The mice were housed in groups of four to five per cage in a light-(12 hour light/dark cycle, lights on at 6 a.m.), humidity-and temperature-controlled room. Food and water were available ad lib. The mice were single housed after the stereotaxic injection of recombinant adenovirus. All animal procedures were approved by the University of Texas Medical Branch Animal Care and Use Committee.
Amygdaloid injection of recombinant adenovirus-
The high titer recombinant adenoviruses (10 10-12 active viral particle/ml), P 1A -5HT 1A -AS-Ad and P 2C -5-HT 2C -S-Ad were injected into the amygdala using stereotaxic techniques. Mice were anesthetized with Avertin (375 mg/kg, ip) and placed on a stereotaxic apparatus. To prevent tissue damage induced by the high salt viral-storage solution, the high titer adenoviruses (about 30 μl) were dialyzed with saline (about 1L) for at least 30 min at 4°C followed by 1:1 dilution with saline prior the injection. The dialyzed viral solution was kept in ice until injected. The injection was performed using an internal injector (33 gage, C315I, Plastics One Inc, Roanoke, Va) that was connected to a 25 μl Hamilton syringe with PE50 tubing. The syringe was placed on an injection pump (WPI) to control the injection rate. The injector was placed into a 26 gage guide cannula with a tubing length of 2mm below the pedestal, which was then mounted on the stereotaxic device (Plastics One Inc, Roanoke, Va). For bilateral injections into the amygdala, two injectors were held by a double guide cannula (26 gage, C/C distance = 6.4mm, tubing length 2mm below the pedestal, Plastics One Inc, Roanoke, Va). Mice were placed on a stareotaxic device with a mouse adaptor. After an incision, one of the injectors was aligned with bregma and all of the coordinates were re-zeroed. The injector was then moved to the anterior/posterior (e.g −0.7mm) and medial/lateral (e.g ±3.2) coordinates. Two holes aligned with the coordinates were drilled. After being filled with the dialyzed viral solution, the injectors (not guide cannulas) were inserted into the brain at the dorsal/ventral coordinate (e.g −5.7mm). The dialyzed adenovirus was then bilaterally injected into the amygdala (1 μl/site at the coordinates of AP = −0.7 mm, ML = ±3.2 mm and DV = −5.7 mm from Bregma) (Paxinos and Franklin, 2001 ) with a rate of 0.5 μl/min. The needle was left in place for additional 20 min after the injection to allow the viral solution time to penetrate the surrounding tissue and reduce the amount of solution entering needle track. The injectors were then removed and the incision was closed. The sites of injection were verified by location of GFP expression in the amygdala sections. The GFP expression indicates the viral infection. Mice were excluded from the study if no GFP was observed or the GFP was not expressed in either side of the amygdala. The exclusion rate was less 10% of mice injected. No significant tissue damage was observed in sites injected with virus.
Ad-track-Ad, a recombinant adenovirus containing shuttle vector alone, was used as a control. Because P 1A -5-HT 1A -AS-Ad and P 2C -5-HT 2C -S-Ad were generated with full cDNA sequence of 5-HT 1A and 5-HT 2C receptors, respectively, we could not design mismatch or scrambled sequences for these receptors.
Behavioral tests

Elevated plus-maze test (EPM):
was performed as described by Holmes et al. (Holmes et al., 2000) . The EPM apparatus (San Diego Instruments, San Diego, CA) was comprised of two open arms (30 × 5 × 0.3 cm) and two enclosed arms (30 × 5 × 15 cm) that extend from a common central platform (5 × 5 cm). A small raised lip (0.5 cm) around the perimeter of the open arms prevented the mouse from falling. The apparatus was constructed from polypropylene and plexiglas, with a white floor and clear walls, and elevated to a height of 38 cm above floor level. The apparatus was evenly illuminated by white overhead fluorescent lighting. Briefly, a mouse was placed on the center of the EPM facing one of the open arms. The mouse was allowed to freely explore the maze for 5 min. Mouse movements were recorded by a video camera. The distance traveled, the time spent and the entries in opened and closed arms were analyzed using a computer-based tracking program (Smart, San Diego Instruments, San Diego, CA). The total distance traveled, total entries and entries in closed arms were used as an index of the locomotor activity. The percent of time spent, the distance traveled and entries in the open arms were used as measurements of anxiety-like behavior. (Holmes et al., 2003a) . The open field was a square area (40 × 40 × 35 cm) with clear plexiglas walls and floor, evenly illuminated by white overhead fluorescent lighting. Mice were individually placed in the center of the open field and left to freely explore for 15 min. Activity was measured by a computer-based tracking program (Smart, San Diego Instruments, San Diego, CA). Distance traveled and time spent in the peripheral and the center areas (20 × 20 cm in the center of the box) of the open field were analyzed. The total distance traveled and the percent of time spent in the center were used to indicate the locomotor activity and anxiety-like behavior, respectively.
Open field test: was conducted as described by Holmes et al
Experimental procedures
2.2.4.1. The effect of amygdaloid 5-HT 1A receptors on anxiety-like behaviors: 5-HT 1A receptors in the amygdala were reduced by injection of P 1A -5HT 1A -AS-Ad into the amygdala. The high titer P 1A -5HT 1A -AS-Ad (10 10 active viral particle/ml) was injected into the amygdala with stereotaxic technique as described above. Another group of mice received a control adenovirus, Ad-track-Ad (10 10 active viral particle/ml), that contains viral vector alone. Five days after the injection, an EPM test was conducted. On the next day (day 6 after the injection) mice were tested in the open field apparatus. Twenty-four hours after the open-field test (day 7 after the injection), mice were decapitated and the brains were collected for autoradiography of 125 I-MPPI binding to determine the reduction of 5-HT 1A receptors. The test schedule was based on our previous data that the peak of adenovirus infection and knockdown of 5-HT 1A receptors was 5-10 days (Li et al., 2004) .
Evaluation of P 2C -5HT 2C -S-Ad:
To determine the selectivity of P 2C -5HT 2C -S-Adinduced expression of 5-HT 2C receptors, we injected P 2C -5HT 2C -S-Ad into the amygdala and cerebellum and compared the expression of 5-HT 2C receptors in these regions. As described in section 2.2.2, P 2C -5HT 2C -S-Ad was unilaterally injected into the amygdala or cerebellum (coordinates: AP= −6.3mm, ML= 0.5mm and DV= −2mm) with a rate of 0.5μl/ min followed by the injector staying in place for an additional 20 min. Seven days after the injection, the mice were sacrificed and brains were collected. The brains were sectioned into 16 μm sections for autoradiography of 125 I-DOI binding to determine the over-expression of 5-HT 2C receptors in the amygdala and cerebellum. The GFP expression was observed to estimate viral expression.
To determine time-course of P 2C -5HT 2C -S-Ad-induced over expression of 5-HT 2C receptors, we injected P 2C -5HT 2C -S-Ad into the amygdala as described in 2.2.2. Three, seven and ten days after the injection, the mice were sacrificed and the brains were sectioned for autoradiography of 125 I-DOI binding assay to determine the over-expression of 5-HT 2C receptors as described in 2.3.
The effect of amygdaloid 5-HT 2C receptors on anxiety-like behaviors:
To overexpress 5-HT 2C receptors in the amygdala, high titer P 2C -5HT 2C -S-Ad (10 11 active viral particle/ml) or Ad-track-Ad were bilaterally injected into the amygdala of mice as described above. Five days after the injection, mice were tested in the EPM.. Then, the open field test was conducted in these mice on the following day (day 6 after the injection). On day 7, the mice were sacrificed and brains were collected.. The brains were collected for autoradiography of 125 I-DOI binding to determine the density of 5-HT 2C receptors in the amygdala.
Autoradiography of receptor ligand binding
Autoradiographies of 125 I-MPPI, a 5-HT 1A antagonist, binding and 125 I-DOI, a 5-HT 2A/2C agonist, binding were conduced to measure the density of 5-HT 1A and 5-HT 2C receptors, respectively. Coronal brain sections (16 μm) containing amygdala (bregma −0.7 to ~ −1.94 mm) were cut using a cryostat and mounted on gelatin-coated slides. Each slide contained 8-12 sections from 4 levels of rostral-caudal amygdala. For each receptor binding assay, two slides were used for total binding and one slide was used for non-specific binding.
Autoradiography of 125 I-MPPI binding for the density of 5-HT 1A receptors was performed using a procedure modified from Kung et al (Kung et al., 1995) as previously described (Li et al., 2000) . Briefly, the sections were pre-incubated in the assay buffer (50 mM Tris-HCl, pH 7.4, containing 200 nM MgCl 2 ) for 30 min and then incubated with 0.14 nM 125 I-MPPI (Kd=0.36 nM) (Zhuang et al., 1994) in assay buffer for 2 h at room temperature. Nonspecific binding was defined in the presence of 10 −5 M 5-HT. Slides were then washed twice with assay buffer at 4°C for 15 min and rinsed with cold ddH 2 O. After being blowdried with air, the slides were exposed to Kodak Biomax MR film at −80°C for 3-5 days. A set of 125 I microscales (Amersham Biosciences, Piscataway, NJ) was exposed with the slides for calibration of the films.
Autoradiography of 125 I-DOI binding for 5-HT 2C receptors was conducted as previously described (Li et al., 2003) . Because the affinity of DOI for 5-HT 2C receptor is similar to that for 5-HT 2A receptors (Ki= 4 and 0.2 nM for 5-HT 2C and 5-HT 2A receptors, respectively), we used the 5-HT 2A receptor antagonist, spiperone (Ki = 2nM and 2.5 μM for 5-HT 2A and 5-HT 2C receptors, respectively) to block 5-HT 2A receptor binding sites. Briefly, the brain sections were pre-incubated with assay buffer containing 50 mM Tris-HCl (pH 7.4), 0.5mM EDTA, 10 mM MgSO 4 , 0.1% ascorbic acid, 0.1% BSA and 10 μM pargyline for 30 min. Then, the sections were incubated with 0.2nM 125 I-DOI in the presence of 100nM spiperone for 60 min at room temperature. Nonspecific binding was defined by in the presence of 10 μM RS 102221, a 5-HT 2C antagonist (Ki = 4nM and 1 μM for 5-HT 2C and 5-HT 2A receptors, respectively). After washing two times with assay buffer at 4°C for 10 min, then rinsing with cold H 2 O and blow drying with air, the slides were exposed to Kodak Biomax MR film at −80°C for 3-5 days. A set of 125 I microscales (Amersham Biosciences, Piscataway, NJ) was exposed with the slides for calibration of the films.
To analyze autoradiographic images, brain images were digitized and analyzed using AIS image software (Imaging Research Inc., Ontario, Canada). The gray scale density readings were calibrated to nCi/mg of tissue equivalent using the 125 I microscale. The density of nuclei was measured by outlining the nucleus according to the mouse brain atlas (Paxinos and Franklin, 2001) . The receptors in the basolateral (including lateral and basolateral nuclei, BLA), basomedial nucleus (BMA) and central nucleus (CeA) of amygdala were measured ( Fig. 2 and Fig. 5 ). Due to over-expression of 5-HT 2C receptors in the caudate putamen region dorsal to the amygdala observed in some mice, we also examined the density of 5-HT 2C receptors in the region of the caudate putamen (CP, Fig 5) . Specific 125 I-MPPI or 125 I-DOI binding in each nuclei of the amygdala was determined by subtracting the nonspecific binding sites from the total binding sites in each nucleus. Data for the density of each nucleus of individual subjects were the mean of 4-6 adjacent sections.
Data analysis and statistics
All of the data were analyzed by one-way or two-way analysis of variance (ANOVA). If a significant difference was detected, a student-Newman-Keuls post-hoc test was used to evaluate differences between individual groups. A computer program, StatView (Abacus Concepts Inc, Berkeley, CA) was used in all statistical analysis. The data were presented as group means ± SEM of 12-14 mice, unless otherwise noted.
Results
Evaluation of P 2C -5HT 2C -S-Ad
To manipulate the expression of 5-HT 2C receptors, we generated a recombinant adenovirus containing 5-HT 2C receptor sense sequence that is controlled by the 5-HT 2C promoter. In the process of the generation of P 2C -5HT 2C -S-Ad, we found that the 5′-UTR of the 5-HT 2C receptor mRNA is required for the in vivo expression of 5-HT 2C receptors. Similar to the recombinant adenovirus containing 5-HT 1A receptor sequences shown in previous publication (Li et al., 2004) , the P 2C -5HT 2C -S-Ad only spreads in a limited area in the brain after injection. Thus, it is useful to study the function of 5-HT 2C receptors in specific brain regions.
To determine the 5-HT 2C promoter-controlled expression of 5-HT 2C receptors, we compared the expression of 5-HT 2C receptors when P 2C -5HT 2C -S-Ad was injected into the amygdala and cerebellum. The cerebellum normally has low expression levels of 5-HT 2C receptors. If the 5-HT 2C promoter sequence in the P 2C -5HT 2C -S-Ad is able to limit the expression of 5-HT 2C receptors to only the cells that normally express 5-HT 2C receptors, the P 2C -5HT 2C -S-Ad-induced expression of 5-HT 2C receptors should be less in the cerebellum than that in the amygdala. As Fig 1B shows , the expression of 5-HT 2C receptors in the cerebellum was much less than that in the amygdala, although viral expression, indicated by GFP expression, was similar in both regions. These data suggest that the 5-HT 2C promoter sequence is able to control 5-HT 2C receptor expression, so that it is mainly expressed in 5-HT 2C receptor positive cells.
To determine the optimal period for viral-mediated 5-HT 2C receptor expression, we conducted a time-course study on P 2C -5HT 2C -S-Ad-induced 5-HT 2C receptor expression. The results showed that a considerable amount of 5-HT 2C receptors was expressed even 3 days after the viral injection. The expression was highest on 7 days and was reduced 10 days after the injection ( Figure 1C ). Based on this data, we conducted further studies on 5-7 days after the viral injection.
Effect of 5-HT 1A receptors in the amygdala on anxiety-like behaviors
5-HT 1A receptors are distributed in the central nucleus (CeA) and basomedial nucleus (BMA) of amygdala. The density of 5-HT 1A receptors in the basolateral nucleus of amygdala (BLA) is relatively low. Since we hypothesized that 5-HT 1A receptors in the CeA may be related to the regulation of anxiety-like behaviors, the injection of adenovirus was targeted to the dorsal region of the amygdala, including CeA and BLA. Injection of P 1A -5HT 1A -AS-Ad into the amygdala significantly reduced the density of 5-HT 1A receptors in the CeA and BLA nuclei (One way ANOVA for CeA: F (1,28) = 13.33, P< 0.01; For BLA: F (1,24) = 5.1, P< 0.05). In the BMA, 5-HT 1A receptor binding sites were not significantly reduced by P 1A -5HT 1A -AS-Ad, although they were lower than in Ad-track treated mice (Fig. 2) . This could be due to an inconsistent infection of P 1A -5HT 1A -AS-Ad.
Anxiety-like behavior of mice was indicated by the time spent, distance traveled and number of entries in the open arms of the EPM. The longer the mouse stays in the open arms, the less anxious the mouse is. On the other hand, the total distance, total number of entries and the number of entries into the closed arms can be used as an index for locomotor activity. The results from the EPM test showed that the percent of distance traveled (%D), the percent of time spent (%T) and the number of entries (open NE) in the open arms were significantly reduced in P 1A -5HT 1A -AS-Ad treated mice relative to the mice that received Ad-track-Ad (Fig 3A) (One-Way ANOVA for %D: F (1,24) = 6.18, P< 0.05, for %T: F (1,24) = 5.38, P< 0.05, for open NE: F (1,25) =7.74, P<0.05). Although the total distance traveled was reduced in P 1A -5HT 1A -AS-Ad treated mice relative to that in Ad-track-Ad treated mice (One-way ANOVA: F (1,24) = 6.18, P< 0.05), the total number of entries and number of entries in closed arm were not changed (Fig. 3A ).
An open field test was performed to further evaluate the locomotor activity of these mice. The total distance traveled in the open field test was not significantly changed in the P 1A -5HT 1A -AS-Ad-treated mice, suggesting that the locomotor activity is not altered in P 1A -5HT 1A -AS-Ad-treated mice (Fig 3B) . Consistent with the lowered anxiety-like behavior in the EPM, the open field test showed that the percent of distance traveled and time spent in the center were significantly reduced in P 1A -5HT 1A -AS-Ad mice (One-way ANOVA for (% center distance: F (1,14) =4.966, P<0.05; and for (% center time: F (1,13) =4.878, P<0.05) (Fig. 3B) .
To determine in which sub-region of the amygdala 5-HT 1A receptors may be related to anxiety-like behavior, the regression coefficients between the density of 5-HT 1A receptors in each sub-region of the amygdala and the percent of time spent and distance traveled in open arms of EPM were calculated. The results showed that the density of 5-HT 1A receptors in the central nucleus of amygdala was correlated with the % of time spent and distance traveled in open arms (R = 0.8, P< 0.01 and R = 0.735, P<0.05 for percent of time spent and distance traveled in open arms, respectively) (Fig. 4) . This correlation was not observed in the basomedial or basolateral nuclei (Fig. 4) .
Effect of 5-HT 2C receptors in the amygdala on anxiety-like behaviors
To determine the effect of amygdaloid 5-HT 2C receptors, we injected P 2C -5HT 2C -S-Ad into the amygdala, especially targeting the BLA, because the BLA contains a relatively high density of 5-HT 2C receptors. Injection of P 2C -5HT 2C -S-Ad significantly increased the expression of 5-HT 2C receptors in the BLA (One-way ANOVA: F (1,20) =10.9, P<0.01, Fig.  5 ). The density of 5-HT 2C receptors in other nuclei in the amygdala was not significantly altered (Fig. 5) . To determine whether injection of P 2C -5HT 2C -S-Ad affected the expression of 5-HT 2C receptors in the adjacent brain regions, we also examined the density of 5-HT 2C receptors in the caudoputamen region (CP) located dorsal to the BLA. The density of 5-HT 2C receptors in the CP was not significantly altered in P 2C -5HT 2C -S-Ad treated mice. The unchanged density of 5-HT 2C receptor could be due to inconsistent viral infection.
In EPM test, mice injected with P 2C -5HT 2C -S-Ad showed a significant reduction in the distance traveled (%D), time spent (%T) and number of entries (NE open) in open arms relative to the control-virus injected mice (One-way ANOVA for %D: F (1,13) =21.75, P<0.01; for %T: F (1,13) =37.05, P<0.01, and for NE open: F (1,12) =5.86, P<0.05). On the other hand, total distance traveled and the number of total entries were not significantly changed in P 2C -5HT 2C -S-Ad-injected mice, whereas the number of entries in closed arms was significantly increased in P 2C -5HT 2C -S-Ad-injected mice (One-way ANOVA for the number of entries in closed arms: F (1,12) =5.82, P<0.05, Fig. 6a ). Unexpectedly, in Ad-track injected mice, the %T and %D in the open arms were higher in the present study than those in other studies, including the Ad-track injected mice in the 5-HT 1A antisense study above. Thus, it is unlikely that the increased %T and %D in the open arms of the Ad-track injected mice is due to the viral injection. We do not have good explanation for the increase, and it could be due to random variation among mice.
Similarly, the distance traveled and time spent in the center of open field were also reduced in P 2C -5HT 2C -S-Ad injected mice relative to mice injected with Ad-track (One-way ANOVA for %D: F (1,16) =6.05, P<0.05; for %T: F (1,16) =8.3, P<0.01, Fig. 6b ). On the other hand, the total distance traveled was not significantly altered in P 2C -5HT 2C -S-Ad-treated mice relative to Ad-track injected mice (Fig. 6b) , suggesting that increases in the distance traveled and time spent in the open arms are unlikely due to alterations in locomotor activity. These data suggest that increase in the expression of 5-HT 2C receptors in the amygdala increases anxiety-like behaviors in mice. Interestingly, the degree of P 2C -5HT 2C -S-Ad-induced reductions in the distance traveled and time spent in the center of open field was much less than those in the open arms of EPM, suggesting that P 2C -5HT 2C -S-Adinduced fear of heights may be more extensive than their fear of novelty.
To determine the sub-region of the amygdala in which 5-HT 2C receptors may be related to anxiety-like behavior, the regression coefficients between the density of 5-HT 2C receptors in each sub-region of the amygdala and the percent of time spent and distance traveled in open arms of EPM were calculated. The results showed that the density of 5-HT 2C receptors in the basolateral nucleus of amygdala (BLA) was correlated with the % of distance traveled on open arms (R = 0.95, P< 0.01). Although the % of time spent in open arms had strong trend to correlate with the density of 5-HT 2C receptors in the BLA, it did not reach statistical significance(R=0.8, P = 0.058) (Fig. 7) . Interestingly, the % of time spent in open arms was significantly correlated with the density of 5-HT 2C receptors in the center nucleus of amygdala (CeA, R=0.797, P<0.05). This correlation was not observed in other sub-regions of amygdala and caudate putamen that is located dorsal to the amygdala (Fig 7) . These data suggest that the 5-HT 2C receptors in the BLA and probably CeA may involved in the regulation of anxiety-like behaviors in mice.
Discussion
Stimulation of 5-HT 1A receptors and 5-HT 2C receptors produce anxiolytic and anxiogenic effects, respectively (Holmes, 2008) . However, the neuro-circuitries and brain regions mediating these effects are still unclear. In the present studies, we provide the first direct evidence, using molecular approaches, to demonstrate the involvement of amygdaloid 5-HT 1A and 5-HT 2C receptors in the regulation of anxiety-like behaviors. Reduced expression of 5-HT 1A receptors in the central nucleus of the amygdala increased anxiety-like behaviors. On the other hand, increased expression of 5-HT 2C receptors in the basolateral nucleus of the amygdala enhanced anxiety-like behaviors. Furthermore, these data suggest that 5-HT 1A and 5-HT 2C receptors in the central nucleus and basolateral nucleus of the amygdala, respectively, regulate anxiety-like behaviors in an opposite direction.
Two behavioral tests, an EPM and an open field test, were performed in the present studies. The EPM is a typical test for anxiety-like behaviors. Naïve EPM test is related to exploratory responses and anxiety produced by the open space and height of the apparatus. Measures of activity in the open arms of the EPM (time spent, entries and distance traveled) are used as indices of anxiety-like behaviors. On the other hand, the total distance traveled, the number of total entries and the number of entries into the closed arms can be used as an index of locomotor activity. The open field test measures locomotor activity by calculating the total distance traveled, whereas the percent of time spent and distance travelled in the center of the field can be used as an index of anxiety-like behaviors. In the present studies, a reduction of 5-HT 1A receptors and an increase of 5-HT 2C receptors in the amygdala significantly attenuated the time and movement in the open arms of EPM and the center of open field. The consistent results from these two tests strongly suggest that 5-HT 1A receptors and 5-HT 2C receptors in the amygdala are related to anxiety-like behaviors. Unlike the results for anxiety-like behaviors, the total distance traveled in the EPM and open field tests were not consistent in P 1A -5HT 1A -AS-Ad treated mice, although the number of total entries and entries into the closed arms in EPM were not altered in these mice relative to the Ad-track treated mice. The total distance traveled in the P 1A -5HT 1A -AS-Ad injected mice was reduced in EPM, but not changed in open field test. Since the open field test mainly measures locomotor activity whereas EPM determines anxiety-like behavior, the data from open field test are a more reliable index for the locomotor activity of the P 1A -5HT 1A -AS-Ad injected mice. Furthermore, the other two measures of locomotor activity in EPM, the number of total entries and number of entries in the closed arms, were not changed in P 1A -5HT 1A -AS-Ad treated mice, suggesting that the locomotor activity of these mice may be not altered. The reduced total distance traveled in P 1A -5HT 1A -AS-Ad treated mice could result from the increased anxiety-like behavior.
5-HT 1A receptors are involved in the regulation of anxiety behaviors. The most convincing evidence for the effects of 5-HT 1A receptors on anxiety behaviors is that mice lacking 5-HT 1A receptors are more anxious (Groenink et al., 2003; Ramboz et al., 1998; Toth, 2003) . 5-HT 1A agonists, such as buspirone, have been used as anxiolytic drugs in humans. Studies suggest that 5-HT 1A receptors in different brain regions may play different roles in the regulation of anxiety behaviors (Graeff and Zangrossi, 2010; Millan, 2003) . Thus, it is important to find the brain regions that are related to the relatively high density of 5-HT 1A receptors located in the central nucleus of amygdala, the data concerning whether 5-HT 1A receptors in the amygdala are involved in regulation of anxiety behaviors were not consistent. Our present results demonstrated that 5-HT 1A receptors in the amygdala, especially in the central nucleus, play an anxiolytic role in mice. This result is consistent with our previous findings in SERT knockout mice. The density of 5-HT 1A receptors in the central nucleus of amygdala is reduced (Li et al., 2000) and, correspondingly, anxiety-like behaviors measured by exploratory tests are increased in the SERT knockout mice relative to their SERT normal littermates (Holmes et al., 2003a) . However, our present results are not consistent with those studies using pharmacological approaches to determine the effects of amygdaloid 5-HT 1A receptors on anxiety-like behaviors in rats. The results from the pharmacological studies showed that injection of 5-HT 1A receptor agonists into the amygdala either produced an anxiogenic effect or had no effect on anxiety-like behavior tested by EPM (Gonzalez et al., 1996; Graeff et al., 1993; Zangrossi and Graeff, 1994) . These differences could be due to the location of the injections of the 5-HT 1A receptor agonist which was targeted to the BLM, a region with a low density of 5-HT 1A receptors and is not significantly related to anxiety-like behaviors measured by EPM as the present data show. Another possible reason for the difference could be the duration of alterations in the activity of 5-HT 1A receptors in the amygdala. The expression of 5-HT 1A receptors was reduced for days in viral-injected mice or for an entire lifetime in knockout mice, whereas acute injection of a 5-HT 1A agonist induces activation of 5-HT 1A receptors for only minutes. Additionally, we could not rule out the possibility of species differences, since most pharmacological studies were conducted in rats but the viral study and knockout studies were in mice. On the other hand, the 5-HT 1A receptors in the amygdala may not mediate other anxiety-like behaviors. Overstreet et al (Overstreet et al., 2006) reported that withdraw from repeated ethanol administration induces a reduction in social interaction which is considered to be a different type of anxiety-like behavior. The social interaction deficits can be reduced by activation of 5-HT 1A receptors in the raphe nuclei but not in the amygdala. These data suggest that neurocircuitries mediating anxiety-related exploratory behaviors may be different from those mediating anxiety-related social interaction behaviors.
Evidence for the anxiogenic effect of 5-HT 2C receptors was initially provided by studies using a non-selective 5-HT agonist, mCPP, which produces anxiogenic effects. The effect of mCPP can be blocked by 5-HT 2C antagonists (Bagdy et al., 2001; Hackler et al., 2007) . Recent studies demonstrated that anxiety-like behavior is reduced in 5-HT 2C receptor knockout mice (Heisler et al., 2007) . Furthermore, stress-induced c-fos expression in the amygdala is reduced in 5-HT 2C knockout mice (Heisler et al., 2007) , suggesting that the amygdala may mediate 5-HT 2C receptor-induced anxiogenic effects. It has been reported that administration of mCPP into the amygdala reduced the time spent in the center of the open field and a 5-HT 2C receptor antagonist reversed this action (Campbell and Merchant, 2003; Cornelio and Nunes-De-Souza, 2007) . Furthermore, Christianson et al reported recently that 5-HT 2C receptors in the BLA are related to uncontrollable traumatic stressinduced anxiety-like behavior in rats (Christianson et al., 2010) . In the present study, we used a molecular approach to over-express 5-HT 2C receptors in the amygdala, which avoids the limitations of pharmacological approaches. The consistency of the present results with those reports from pharmacological studies further support our hypothesis that an increase in the activity of 5-HT 2C receptors in the amygdala, especially in the basolateral nucleus, produces an anxiogenic effect. Interestingly, our results also showed a correlation between the density of 5-HT 2C receptors in the central nucleus of amygdala and the time spent in the open arms of EPM, even though 5-HT 2C receptors were not significantly increased by viral infection. These data suggest that the physiological levels of 5-HT 2C receptors in the central nucleus of amygdala may also be related to the regulation of anxiety-like behaviors.
As a fear center, the amygdala can be divided into at least two subgroups, the basolateral nuclei and the centromedial nuclei (LeDoux, 2003; Sah et al., 2003) . The basolateral subdivision includes lateral (LA), basal lateral (BLA) and basal medial (BMA) nuclei. They receive sensory inputs from prefrontal cortex and other brain regions and then send the information to the centromedial subdivision. Additionally, neurons in the basolateral nuclei also project to other brain regions, such as the prefrontal cortex, striatum and nucleus accumbens. These innervations of the basolateral amygdala may be related to learning and memory (Abe et al., 2009; Duvarci and Nader, 2004; Ehrlich et al., 2009; Maren, 2008) . The centromedial subdivision contains the central nucleus, medial nucleus and part of the bed nucleus of stria terminalis. These nuclei receive the inputs from basolateral subdivision and project to other brain regions, such as the hypothalamus, hippocampus and brainstem to express the fear and anxiety behaviors. Furthermore, the interaction between the amygdala and hippocampus is related to acquisition and extinction of fear learning and memory. Evidence indicates that the amygdaloid neurons involved in regulation of anxiety and fear conditioning are signaling through glutamatergic and GABAergic neurotransmitter systems (Roozendaal et al., 2009 ). The present results suggest that stimulation of 5-HT 1A receptors in the central nucleus of amygdala reduces anxiety-like behaviors, suggesting that an inhibitory signaling pathway may be involved. On the other hand, activation of 5-HT 2C receptors in the lateral nucleus and basolateral nucleus of amygdala enhances anxiety-like behaviors, suggesting excitatory signaling neuro-circuitries. It will be important to determine the types of neurons containing 5-HT 1A receptors in the central nucleus and 5-HT 2C receptors in the basolateral nucleus of amygdala. Although we did not find an association between 5-HT 1A and 5-HT 2C receptors in the basomedial nucleus of amygdala and alterations in anxiety-like behaviors in the present studies, we cannot rule out the role of these receptors in the BMA in regulation of anxiety-like behaviors because they were not significantly changed in the present studies.
Altogether, the present results provide information concerning the effects of serotonergic receptors in the amygdaloid nuclei on regulation of anxiety behaviors. This knowledge will have a significant impact on future studies of the neuro-circuitries that regulate anxiety behaviors.
Highlights
• We altered the expressions of 5-HT 1A and 5-HT 2C receptors in the amygdala using adenovirus technique.
• Reduction of 5-HT 1A receptors in the amygdala increased anxiety-like behaviors.
• Increase of 5-HT 2C receptors in the amygdala increased anxiety-like behaviors.
• 5-HT 1A receptors in the CeA and 5-HT 2C receptors in the BLA are important on regulation of anxiety. 
